PRAXIS PRECISION MEDICINES, INC. Increase (Decrease) in Prepaid Expense and Other Assets
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Increase (Decrease) in Prepaid Expense and Other Assets of $2.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.86M.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$672.00K.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $4.89M, a 44.32% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.38M.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$640.00K, a 107.78% decline from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $8.22M.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$6.77M.
- PRAXIS PRECISION MEDICINES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$547.00K, a 109.46% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.19M 10-Q · filed 2026-08-06 | $7.08M derived: sum of 3 quarters · filed 2026-08-06 | $8.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$672.00K 10-Q · filed 2026-05-07 | $4.22M derived: sum of 2 quarters · filed 2026-05-07 | $5.61M derived: sum of 3 quarters · filed 2026-05-07 | $5.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.28M derived: sum of 2 quarters · filed 2026-02-19 | $6.00M derived: sum of 3 quarters · filed 2026-08-06 | -$640.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.10M derived: sum of 2 quarters · filed 2026-08-06 | -$5.53M 10-Q · filed 2025-11-05 | $3.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$6.92M 10-Q · filed 2026-08-06 | $1.87M derived: sum of 3 quarters · filed 2026-08-06 | $51.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$6.64M 10-Q · filed 2026-05-07 | $2.15M derived: sum of 2 quarters · filed 2026-05-07 | $331.00K derived: sum of 3 quarters · filed 2026-05-07 | $780.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.97M derived: sum of 2 quarters · filed 2026-02-19 | $7.42M derived: sum of 3 quarters · filed 2026-02-19 | $8.22M 10-K · filed 2026-02-19 |
| 2024-09-30 | -$1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.37M derived: sum of 2 quarters · filed 2025-11-05 | -$564.00K 10-Q · filed 2025-11-05 | $773.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $1.26M 10-Q · filed 2025-08-04 | $2.59M derived: sum of 3 quarters · filed 2026-02-19 | -$693.00K derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $808.00K 10-Q · filed 2025-05-02 | $2.15M derived: sum of 2 quarters · filed 2026-02-19 | -$1.14M derived: sum of 3 quarters · filed 2026-02-19 | -$4.19M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$1.95M derived: sum of 2 quarters · filed 2026-02-19 | -$5.00M derived: sum of 3 quarters · filed 2026-02-19 | -$6.77M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$6.34M derived: sum of 2 quarters · filed 2024-11-06 | -$8.11M 10-Q · filed 2024-11-06 | -$6.33M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$4.82M 10-Q · filed 2024-08-13 | -$3.04M derived: sum of 3 quarters · filed 2024-08-13 | -$4.65M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$1.77M 10-Q · filed 2024-05-13 | $8.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.60M derived: sum of 3 quarters · filed 2024-05-13 | -$3.38M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $175.00K derived: sum of 2 quarters · filed 2024-03-05 | -$1.61M derived: sum of 3 quarters · filed 2024-03-05 | -$547.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | -$1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.39M derived: sum of 2 quarters · filed 2023-11-07 | -$2.33M 10-Q · filed 2023-11-07 | $4.20M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$722.00K 10-Q · filed 2023-08-09 | $5.81M derived: sum of 3 quarters · filed 2023-08-09 | $1.53M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $1.06M 10-Q · filed 2023-05-11 | $7.59M derived: sum of 2 quarters · filed 2023-05-11 | $3.31M derived: sum of 3 quarters · filed 2023-05-11 | $4.81M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $2.25M derived: sum of 2 quarters · filed 2023-02-07 | $3.75M derived: sum of 3 quarters · filed 2023-02-07 | $5.78M 10-K · filed 2023-02-07 |
| 2021-09-30 | -$4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.78M derived: sum of 2 quarters · filed 2022-11-09 | -$749.00K 10-Q · filed 2022-11-09 | $3.29M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.53M 10-Q · filed 2022-08-08 | $7.57M derived: sum of 3 quarters · filed 2022-08-08 | $7.96M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $2.04M 10-Q · filed 2022-05-09 | $6.07M derived: sum of 2 quarters · filed 2022-05-09 | $6.46M derived: sum of 3 quarters · filed 2022-05-09 | $6.18M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $4.43M derived: sum of 2 quarters · filed 2022-02-28 | $4.14M derived: sum of 3 quarters · filed 2022-02-28 | $4.44M 10-K · filed 2022-02-28 |
| 2020-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $104.00K derived: sum of 2 quarters · filed 2021-11-03 | $398.00K 10-Q · filed 2021-11-03 | $732.00K derived: sum of 4 quarters · filed 2021-11-03 |
| 2020-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $11.00K 10-Q · filed 2021-08-16 | $345.00K derived: sum of 3 quarters · filed 2021-08-16 | |
| 2020-03-31 | $294.00K 10-Q · filed 2021-05-11 | $628.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$495.00K 10-K · filed 2021-03-17 | ||
| 2019-09-30 | -$829.00K 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |